Roivant Sciences pulls in $200 mln
Roivant Sciences, a biotech holding company, has secured $200 million in financing. The investors included NovaQuest Capital Management and RTW Investments.
14 November 2018•1 min read
Roivant Sciences, a biotech holding company, has secured $200 million in financing. The investors included NovaQuest Capital Management and RTW Investments.
